4//SEC Filing
Owen Catherine E. 4
Accession 0001439222-24-000077
CIK 0001439222other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:15 PM ET
Size
7.0 KB
Accession
0001439222-24-000077
Insider Transaction Report
Form 4
Owen Adams Catherine
Director
Transactions
- Exercise/Conversion
Common stock
2024-06-13+1,976→ 1,976 total - Exercise/Conversion
Restricted stock units
2024-06-13−1,976→ 3,953 total→ Common stock (1,976 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001816838
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:15 PM ET
- Size
- 7.0 KB